Vimarsana
Biggest News Aggregation in the World

Page 16 - Docket Number News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Docket Number. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Docket Number Today - Breaking & Trending Today

Technical Considerations for Medical Devices with Physiologic Closed-Loop Control Technology - Vimarsana News

Technical Considerations for Medical Devices with Physiologic Closed-Loop Control Technology

Technical considerations for development of medical devices employing physiologic closed-loop control technology to ensure safe and effective use in patients.

Source: fda.gov
Draft Guidance for Industry: Hazard Analysis and Risk-Based Preventive Controls for Human Food - Vimarsana News

Draft Guidance for Industry: Hazard Analysis and Risk-Based Preventive Controls for Human Food

This draft guidance, when finalized, will represent the current thinking of the Food and Drug Administration (FDA or we) on Hazard Analysis and Risk-Based Preventive Controls for Human Food.

Source: fda.gov
Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions - Vimarsana News

Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions

This document provides FDA’s recommendations regarding premarket submissions of devices with cybersecurity risk.

Source: fda.gov
Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications - Vimarsana News

Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications

Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications

Source: fda.gov
Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies - Vimarsana News

Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies

Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies

Source: fda.gov